Exploring the Relationship Between Stimulant Use and Serious Mental Illness-View Presentation

Video Transcription

Video Summary

Dr. Rob Cotez, Director of the Clinical and Research Program for Psychosis at Grady Health System and Associate Professor at Emory University School of Medicine, introduced a webinar on the relationship between stimulant use and serious mental illness. The webinar was part of the SMI Advisor initiative, which aims to provide evidence-based care for individuals with serious mental illness. The webinar covered topics such as stimulant-induced psychosis, the differences between stimulant and primary psychosis, and evidence-based treatments for stimulant use disorders. The presenters discussed the effects of different stimulants, including cocaine and methamphetamine, and how they can cause psychosis. They highlighted the unique characteristics of stimulant-induced psychosis, such as transient ideas of reference and tactile hallucinations. They also discussed the emergence of potent forms of methamphetamine, known as M2B methamphetamine, and its impact on overdose presentations. The presenters emphasized the importance of behavioral therapies and contingency management in the treatment of stimulant use disorders. They also discussed the use of antipsychotic medications for individuals with methamphetamine-induced psychosis and the need for individualized treatment plans. The presenters concluded by discussing the role of policy in addressing stimulant use and serious mental illness and the importance of wraparound services and coordinated care.

Keywords

Dr. Rob Cotez

stimulant use

serious mental illness

webinar

stimulant-induced psychosis

evidence-based treatments

cocaine

methamphetamine

behavioral therapies

antipsychotic medications